14mg semaglutide tablets Semma Tablet Rybelsus 14mg Tablet 10s: View

Data sources The input parameters for the benefit-harm balance modelling were the relative treatment effects of GLP-1 RAs as compared to placebo, the benefit and harm outcome incidences in untreated individuals, and preference weights (relative importance) of the outcomes.24, 25, 26, 27 A careful selection of valid and applicable evidence relevant to the given decision context is a key step in a benefit-harm analysis.28, 29, 30 The relative treatment effect and baseline risks were obtained from RCTs

JAMA Neurology (2013) 11

31, 881890.10.1017/S003329170100407X 206 LucasA

Baseline gastric testing and provider assessment determine individual risk and feasibility

Depending on bulk density and capsule size, the project may require multiple capsules, a tablet, a sachet or a powder format

The pen is pre-filled with 4 doses